Buchanan Adds Prominent FDA Practitioner Linda Pissott Reig to its Ranks

Newark, NJ, February 14, 2011 — Buchanan Ingersoll & Rooney welcomes Linda Pissott Reig as a shareholder in its FDA / Biotechnology Practice. Reig was principal of her former New Jersey-based law firm and served as vice president of compliance services for its pharmaceutical services subsidiary.

"Buchanan's reputation for providing integrated FDA services—from pharmaceutical/ biotechnology industry depth to a strong federal government relations team in D.C.—was a key reason for my move," says Reig. "My clients will benefit from the larger platform and complementary practices that Buchanan offers."

Edward John Allera, who chairs the firm's FDA Practice, says, "Linda's depth in the pharmaceutical industry and her extensive knowledge in the areas of marketing and selling FDA-regulated products mesh perfectly with our team's strengths." He adds, "her prominence in the New Jersey market also adds breadth to our practice, which includes mostly D.C.-based lawyers."

Reig is co-chair of the BioNJ Legal Forum Advisory Committee, which she was instrumental in forming in 2008.  The committee is comprised of in-house counsel and compliance representatives from top-ranking NJ-based biotechnology companies who discuss new legal developments and put together programs of interest to the NJ-based biotechnology community.  She has been recognized by New Jersey Law Journal in their annual “40 Under 40” list of attorneys, named in 2006-2008 among New Jersey Super Lawyers Rising Stars and received an AV rating in the Martindale-Hubbell Law Directory. She also received the Alumni Meritorious Service Award presented by Rutgers University.

About Linda Pissott Reig
Linda Pissott Reig counsels companies on lawful marketing and sale of prescription drugs, medical devices and biologics. She reviews promotional materials (including broadcast ads, print materials, internet/social media) and evaluates marketing initiatives, such as physician speaker programs and patient support groups. For companies awaiting FDA approval, she provides guidance on lawful preapproval communication strategies. Reig also advises on compliance with industry standards for clinical trial set-up and oversight, including recruitment of investigators and subjects. She conducts training for life sciences companies on compliance topics.

She prepares Standard Operating Procedures and Policies for corporate compliance programs, negotiates and drafts agreements and advises on consulting arrangements with key opinion leaders. In addition, she advises on pharmacovigilance, advisory boards, continuing medical education grants, charitable contributions and labeling changes. Linda guides companies on how to minimize legal risk while achieving business objectives.

On the state law side, Linda assists companies with their state law obligations, such as aggregate spend, marketing disclosures, data-mining, clinical trial disclosure, adherence to compliance codes, sales representative licensure and manufacturing/distribution licensure.

Before joining Buchanan, Linda worked as in-house counsel (while on secondment) for a pharmaceutical company part-time for five years. While an associate, Linda litigated commercial disputes, as well as products liability/consumer fraud claims (both individual suits and class actions) arising from use of pharmaceuticals and medical devices. She served as a judicial clerk for the Honorable Marie L. Garibaldi, the first woman justice appointed to the New Jersey Supreme Court. Reig received her B.A. degree, summa cum laude, from Rutgers University Newark College of Arts & Sciences, and her J.D. degree, cum laude, from Georgetown University Law Center.

About the Firm
Buchanan Ingersoll & Rooney PC has more than 450 attorneys and government relations professionals practicing throughout the United States, with multiple offices in California, Florida, New Jersey, New York and Pennsylvania, as well as offices in Delaware, Virginia and Washington, D.C.

###